NO20070186L - Sammensetninger inneholdende nicorandil, fremstillingsfremgangsmate og anvendelse av sammensetningen - Google Patents

Sammensetninger inneholdende nicorandil, fremstillingsfremgangsmate og anvendelse av sammensetningen

Info

Publication number
NO20070186L
NO20070186L NO20070186A NO20070186A NO20070186L NO 20070186 L NO20070186 L NO 20070186L NO 20070186 A NO20070186 A NO 20070186A NO 20070186 A NO20070186 A NO 20070186A NO 20070186 L NO20070186 L NO 20070186L
Authority
NO
Norway
Prior art keywords
preparation
compositions containing
composition
containing nicorandil
nicorandil
Prior art date
Application number
NO20070186A
Other languages
English (en)
Inventor
Mathieu Nocent
Thierry Bonhomme
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NO20070186L publication Critical patent/NO20070186L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Det er beskrevet sammensetninger inneholdende Nicorandil, en fremgangsmåte for fremstilling derav samt anvendelse derav. Oppfinnelsen vedrører spesielt en fremgangsmåte for fremstilling av sammensetninger inneholdende Nicorandil, sammensetninger oppnådd ved hjelp av nevnte fremgangsmåte, tabletter oppnådd ved direkte kompresjon og deres anvendelse som medisin.
NO20070186A 2004-07-08 2007-01-11 Sammensetninger inneholdende nicorandil, fremstillingsfremgangsmate og anvendelse av sammensetningen NO20070186L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0407590A FR2872705B1 (fr) 2004-07-08 2004-07-08 Compositions contenant du nicorandil, procede de preparation et utilisation
PCT/FR2005/001730 WO2006016040A1 (fr) 2004-07-08 2005-07-05 Compositions contenant du nicorandil, procede de preparation et utilisation

Publications (1)

Publication Number Publication Date
NO20070186L true NO20070186L (no) 2007-01-31

Family

ID=34950297

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070186A NO20070186L (no) 2004-07-08 2007-01-11 Sammensetninger inneholdende nicorandil, fremstillingsfremgangsmate og anvendelse av sammensetningen

Country Status (18)

Country Link
US (1) US20070190134A1 (no)
EP (1) EP1776093A1 (no)
JP (1) JP2008505873A (no)
KR (1) KR20070030262A (no)
CN (1) CN100591356C (no)
AU (1) AU2005271131B2 (no)
BR (1) BRPI0513005A (no)
CA (1) CA2570863A1 (no)
EA (1) EA012967B1 (no)
FR (1) FR2872705B1 (no)
HK (1) HK1107256A1 (no)
IL (1) IL180285A0 (no)
MA (1) MA28783B1 (no)
MX (1) MXPA06015151A (no)
NO (1) NO20070186L (no)
NZ (1) NZ552983A (no)
WO (1) WO2006016040A1 (no)
ZA (1) ZA200700704B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2098249B1 (en) 2008-03-05 2012-10-24 Rivopharm SA Nicorandil carriers with enhanced stability
CN115429763B (zh) * 2021-06-02 2024-01-02 北京四环科宝制药股份有限公司 尼可地尔片剂及其制备方法
CN114732792A (zh) * 2022-03-25 2022-07-12 北京诺康达医药科技股份有限公司 一种尼可地尔口腔崩解片及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3915959A (en) * 1974-03-15 1975-10-28 Crown Zellerbach Corp Activated alkali cellulose and derivatives formed therefrom and a process for making the same
JPS57145659A (en) * 1981-03-06 1982-09-08 Chugai Pharmaceutical Co Ltd Production of tablet
KR940000232B1 (ko) * 1986-01-17 1994-01-12 쥬우가이세이야꾸 가부시끼가이샤 니코란딜 제제의 안정화 방법
ZA87279B (en) * 1986-01-17 1987-09-30 Chugai Pharmaceutical Co Ltd Method for production of stable nicorandil preparation
JP2512302B2 (ja) * 1986-03-19 1996-07-03 中外製薬株式会社 ニコランジル安定化製剤の製造方法
JP2936376B2 (ja) * 1993-09-03 1999-08-23 小林化工株式会社 ニコランジル錠剤の製法
JP3503222B2 (ja) * 1994-11-07 2004-03-02 東和薬品株式会社 ニコランジルの安定化錠剤の製造方法
JPH08175996A (ja) * 1994-12-22 1996-07-09 Taiyo Yakuhin Kogyo Kk ニコランジル安定化固形製剤の製法
JP2535141B2 (ja) * 1995-01-17 1996-09-18 中外製薬株式会社 フマル酸含有徐放性製剤
TW458776B (en) * 1995-08-15 2001-10-11 Chugai Pharmaceutical Co Ltd Pharmaceutical composition for the treatment of anxiety neurosis
JP3947582B2 (ja) * 1995-08-15 2007-07-25 中外製薬株式会社 不安神経症治療剤
JPH10231241A (ja) * 1997-02-19 1998-09-02 T T S Gijutsu Kenkyusho:Kk 服用に水を必要としない錠剤、並びにドライエマルションおよびその製造方法
JPH11189547A (ja) * 1997-12-26 1999-07-13 Taisho Pharmaceut Co Ltd 安定化されたニコランジル製剤及びその製造方法
ATE272395T1 (de) * 1998-05-15 2004-08-15 Chugai Pharmaceutical Co Ltd Präparationen zur kontrollierten freisetzung
JP2001010950A (ja) * 1999-06-29 2001-01-16 Taiyo Yakuhin Kogyo Kk 安定で良好な薬物放出を有する医薬組成物

Also Published As

Publication number Publication date
HK1107256A1 (en) 2008-04-03
CN1980644A (zh) 2007-06-13
US20070190134A1 (en) 2007-08-16
WO2006016040A1 (fr) 2006-02-16
ZA200700704B (en) 2008-10-29
CA2570863A1 (fr) 2006-02-16
FR2872705A1 (fr) 2006-01-13
EP1776093A1 (fr) 2007-04-25
AU2005271131A1 (en) 2006-02-16
NZ552983A (en) 2010-07-30
MA28783B1 (fr) 2007-08-01
EA200700191A1 (ru) 2007-06-29
KR20070030262A (ko) 2007-03-15
BRPI0513005A (pt) 2008-04-22
IL180285A0 (en) 2007-07-04
MXPA06015151A (es) 2007-03-26
JP2008505873A (ja) 2008-02-28
FR2872705B1 (fr) 2008-07-18
CN100591356C (zh) 2010-02-24
EA012967B1 (ru) 2010-02-26
AU2005271131B2 (en) 2010-04-29

Similar Documents

Publication Publication Date Title
NO20084850L (no) MGLUR5 modulatorer I
NO20085373L (no) P38 inhibitorer, deres fremstilling og anvendelse
NO20084712L (no) Nye farmasoytiske forbindelser
NO20064347L (no) Substituerte 1,2,3,4-tetrahydroisokinolinderivater
NO20083918L (no) Dihydridiazepiner anvendelige som inhibitorer av proteinkinaser
NO20073628L (no) Pyridoner som er nyttige som inhibitorer av kinaser
NO20055863L (no) W-karboksyarylsubstituerte difenylureaforbindelser som raf-kinaseinhibitorer
NO20082673L (no) Nye 2-amino-imidazol-4-on forbindelser og deres anvendelse i fremstilling av et medikament som skal brukes til behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerasjon og demens
NO20080785L (no) Behandling av kreft
NO20081729L (no) Nye diazaspiroalkaner og deres anvendelse for behandling av CCR8-medierte sykdommer
NO20071242L (no) Triazolpyridinylsulfanylderivater som P38-MAP-kinaseinhibitorer
EA201070699A1 (ru) Композиции 3-(6-(1-2,2-дифторбензо[d][1,3]диоксол-5-ил)циклопропанкарбоксамидо)-3-метилпиридин-2-ил)бензойной кислоты
NO20090469L (no) Substituerte piperidiner som oker P53-aktiviteten, og anvendelse derav
NO20084923L (no) N-(2-thiazolyl)-amid derivater som GSK-3 inhibitorer
NO20090628L (no) Pyridizinon derivativater
NO20073140L (no) Pyrrolopyraziner og pyralopyraziner som er nyttige som inhibitorer av proteinkinaser
DE602006013940D1 (de) Oral zerfallende zusammensetzung von olanzapin oder donepezil
NO20070487L (no) 3-aminocyklopentankarboksamider som modulatorer av kjemokinreseptorer.
EA200700096A1 (ru) Производные 2-карбамид-4-фенилтиазола, способ их получения и их применение в терапии
TW200616995A (en) Novel compounds
NO20084747L (no) Tetrahydropteridiner anvendbare som inhibitorer av protein kinaser
WO2007143607A3 (en) Method of treating atrophic vaginitis
NO20083845L (no) 2,4-diaminopyrimidiner som celle-cyklus kinase inhibitorer
NO20084852L (no) MGLUR5 modulatorer V
NO341679B1 (no) Substituerte pyridylamidforbindelser, fremstilling av slike og farmasøytiske sammensetninger inneholdende slike, samt anvendelse som modulatorer av histamin H3-reseptoren

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application